Bulletin
Investor Alert

New York Markets Close in:

Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

Market open

/zigman2/quotes/207301221/composite

$

0.69

Change

+0.0071 +1.04%

Volume

Volume 29,209

Feb 6, 2023, 2:27 p.m.

Real time quotes

/zigman2/quotes/207301221/composite

Previous close

$ 0.68

$ 0.69

Change

+0.0071 +1.04%

Day low

Day high

$0.66

$0.80

Open
Open: 0.70

52 week low

52 week high

$0.35

$1.45

Open

Market cap

$29.71M

Average volume

161,847

P/E ratio

N/A

Rev. per Employee

$48,438

EPS

-1.10

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cycn

MarketWatch News on CYCN

  1. Cyclerion Therapeutics started at buy with $14 stock price target at Truist

    6:45 a.m. Oct. 20, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/cycn

Other News on CYCN

  1. 10-Q: CYCLERION THERAPEUTICS, INC.

    4:13 p.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Cyclerion Therapeutics reports Q1 results

    4:40 p.m. May 4, 2022

    - Seeking Alpha

  3. 10-K: CYCLERION THERAPEUTICS, INC.

    4:10 p.m. Feb. 24, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Warning: CYCN is at high risk of performing badly

    4:47 a.m. Nov. 12, 2021

    - Seeking Alpha

  5. Warning: CYCN is at high risk of performing badly

    3:38 a.m. Oct. 22, 2021

    - Seeking Alpha

  6. ME, CYCN and FWBI among pre market gainers

    7:28 a.m. Oct. 20, 2021

    - Seeking Alpha

  7. DPW, ANVS and CFMS among pre market gainers

    7:30 a.m. July 23, 2021

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/cycn

Press Releases on CYCN

  1. Cyclerion Gains on Study Results

    8:57 a.m. June 17, 2022

    - Baystreet.ca

Rates »

Link to MarketWatch's Slice.